Effect of erythropoietin-stimulating agent on uremic inflammation
<p>Abstract</p> <p>Background</p> <p>The goal of the present study was to explore the effect of medications that are commonly prescribed for CKD patients on uremic state.</p> <p>Methods</p> <p>This was a cross-sectional study. From January 2006 t...
Saved in:
Main Authors: | Tanaka Yuri (Author), Joki Nobuhiko (Author), Hase Hiroki (Author), Iwasaki Masaki (Author), Ikeda Masato (Author), Ando Ryoichi (Author), Shinoda Toshio (Author), Inaguma Daijo (Author), Sakaguchi Toshifumi (Author), Komatsu Yasuhiro (Author), Koiwa Fumihiko (Author), Yamaka Toshihiko (Author), Shigematsu Takashi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome
by: Da Eun Woo, et al.
Published: (2016) -
Vascular Calcification in Diabetic Kidney Disease
by: Olivier Phan, et al.
Published: (2022) -
Non-Ischemic Myocardial Fibrosis in End-Stage Kidney Disease Patients: A New Perspective
by: Kenji Nakata, et al.
Published: (2023) -
Uremic stomatitis
by: Ramachandran Sudarshan, et al.
Published: (2012) -
Uremic frost
by: Sujeet Raina, et al.
Published: (2014)